U.S. Code · Título 42
State demonstration grants for comprehensive opioid abuse response
42 U.S.C. § 290ee–3
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Definitions
In this section:
Prescriber
The term “prescriber” means a dispenser who prescribes a controlled substance, or the agent of such a dispenser.
Prescriber of a schedule II, III, or IV controlled substance
The term “prescriber of a schedule II, III, or IV controlled substance” does not include a prescriber of a schedule II, III, or IV controlled substance that dispenses the substance—
Schedule II, III, or IV controlled substance
The term “schedule II, III, or IV controlled substance” means a controlled substance that is listed on schedule II, schedule III, or schedule IV of section 812(c) of title 21.
Grants for comprehensive opioid abuse response
In general
The Secretary shall award grants to States, and combinations of States, to implement an integrated opioid abuse response initiative.
Purposes
A State receiving a grant under this section shall establish a comprehensive response plan to opioid abuse, which may include—
establishing, maintaining, or improving a comprehensive prescription drug monitoring program to track dispensing of schedule II, III, or IV controlled substances, which may—
developing, implementing, or expanding prescription drug and opioid addiction treatment programs by—
Application
A State seeking a grant under this section shall submit to the Secretary an application in such form, and containing such information, as the Secretary may reasonably require.
Use of funds
A State that receives a grant under this section shall use the grant for the cost, including the cost for technical assistance, training, and administration expenses, of carrying out an integrated opioid abuse response initiative as outlined by the State’s comprehensive response plan to opioid abuse established under paragraph (2).
Priority considerations
In awarding grants under this section, the Secretary shall, as appropriate, give priority to a State that—
submits to the Secretary a certification by the attorney general of the State that the attorney general has—
reviewed any applicable civil liability protection law to determine the applicability of the law with respect to first responders, health care professionals, family members, and other individuals who—
Evaluation
In conducting an evaluation of the program under this section pursuant to section 701 of the Comprehensive Addiction and Recovery Act of 2016, with respect to a State, the Secretary shall report on State legislation or policies related to maximizing the use of prescription drug monitoring programs and the incidence of opioid use disorders and overdose deaths in such State.
States with local prescription drug monitoring programs
In general
In the case of a State that does not have a prescription drug monitoring program, a county or other unit of local government within the State that has a prescription drug monitoring program shall be treated as a State for purposes of this section, including for purposes of eligibility for grants under paragraph (1).
Plan for interoperability
In submitting an application to the Secretary under paragraph (3), a county or other unit of local government shall submit a plan outlining the methods such county or unit of local government shall use to ensure the capability of data sharing with other counties and units of local government within the state 1 and with other States, as applicable.
Authorization of funding
For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2017 through 2021.
(July 1, 1944, ch. 373, title V, § 548, as added Pub. L. 114–198, title VI, § 601, July 22, 2016, 130 Stat. 732.)